Immatics NV (IMTX)
10.96
+0.16
(+1.43%)
USD |
NASDAQ |
May 02, 10:16
Immatics Shareholders Equity (Quarterly): 248.81M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 248.81M |
| September 30, 2023 | 262.24M |
| June 30, 2023 | 237.14M |
| March 31, 2023 | 218.18M |
| December 31, 2022 | 228.60M |
| September 30, 2022 | 111.11M |
| June 30, 2022 | 130.51M |
| March 31, 2022 | 129.46M |
| Date | Value |
|---|---|
| December 31, 2021 | 27.24M |
| September 30, 2021 | 40.78M |
| June 30, 2021 | 90.97M |
| March 31, 2021 | 109.83M |
| December 31, 2020 | 107.48M |
| September 30, 2020 | 142.83M |
| June 30, 2020 | -77.04M |
| December 31, 2019 | -46.88M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-77.04M
Minimum
Jun 2020
262.24M
Maximum
Sep 2023
122.58M
Average
120.28M
Median
Shareholders Equity (Quarterly) Benchmarks
| MorphoSys AG | 54.22M |
| Affimed NV | 63.90M |
| InflaRx NV | 113.39M |
| BioNTech SE | 22.38B |
| CureVac NV | 571.43M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 563.72M |
| Total Liabilities (Quarterly) | 314.91M |
| Current Ratio | 2.870 |